{"id":2020,"date":"2021-01-25T20:43:57","date_gmt":"2021-01-25T18:43:57","guid":{"rendered":"http:\/\/interchem.epicstation.com\/product\/rosuvastatin_ic\/"},"modified":"2021-02-18T19:04:23","modified_gmt":"2021-02-18T17:04:23","slug":"rosuvastatin_ic","status":"publish","type":"product","link":"https:\/\/interchem.ua\/en\/product\/rosuvastatin_ic\/","title":{"rendered":"Rosuvastatin IC"},"content":{"rendered":"
Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase, an enzyme that determines the reaction rate and converts 3-hydroxy-3-methylglutaryl coenzyme A into mevalonate, the precursor of cholesterol. The main place of action of rosuvastatin is the liver, the target organ for reducing cholesterol levels.<\/span><\/p>\n Rosuvastatin increases the number of low-density lipoprotein (LDL) receptors on the surface of the liver cells, enhancing the uptake and catabolism of LDL, and inhibits the hepatic synthesis of very low-density lipoproteins (VLDL), thereby reducing the total number of VLDL and LDL particles.<\/span><\/p>\n Trade name:<\/strong> R<\/span>osuvastatin IC <\/p>\n","protected":false},"excerpt":{"rendered":" Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase, an enzyme that determines the reaction rate and converts 3-hydroxy-3-methylglutaryl coenzyme A into mevalonate, the precursor of cholesterol. The main place of action of rosuvastatin is the liver, the target organ for reducing cholesterol levels. Rosuvastatin increases the number of low-density lipoprotein (LDL) receptors on […]<\/p>\n","protected":false},"featured_media":1914,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false},"product_cat":[33],"product_tag":[104],"class_list":{"0":"post-2020","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-drugs-en","7":"product_tag-r","9":"first","10":"instock","11":"product-type-simple"},"acf":[],"yoast_head":"\n
<\/span><\/span><\/span>Pharmaceutical form: <\/strong>tablets – 5 mg, 10 mg, 20 mg and 40 mg
Pharmacotherapeutic group:<\/strong> Lipid-lowering drugs. Inhibitors of HMG-CoA reductase. Rosuvastatin.
Code ATX C10A A07.
Registration number: <\/strong>\u2116UA\/15855\/01\/01, \u2116UA\/15855\/01\/02, \u2116UA\/15855\/01\/03, \u2116UA\/15855\/01\/04
Date of registration \/ valid until:<\/strong> 09.03.2017 \/ 09.03.2022
Packing:<\/strong> tablets \u2116<\/span> 30 (10 × 3) in a blister pack
Shelf life: <\/strong>3 years
Legal category<\/strong>: <\/strong><\/span>p<\/span>rescription only medicine<\/p>\n

<\/p>\n